|
US3145209A
(en)
|
1961-07-31 |
1964-08-18 |
Olin Mathieson |
Substituted aminophenyl-ethylamine derivatives
|
|
US3975443A
(en)
|
1972-06-06 |
1976-08-17 |
Allen & Hanburys Limited |
1-(3,4-dichlorobenzamidomethyl)-cyclohexyldimethylamine
|
|
DE3718317A1
(de)
|
1986-12-10 |
1988-06-16 |
Bayer Ag |
Substituierte basische 2-aminotetraline
|
|
US5032604A
(en)
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Class III antiarrhythmic agents
|
|
DE4302051A1
(de)
|
1993-01-26 |
1994-07-28 |
Thomae Gmbh Dr K |
5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
WO1994020500A1
(en)
|
1993-03-04 |
1994-09-15 |
Pfizer Inc. |
Spiroazacyclic derivatives as substance p antagonists
|
|
ATE216580T1
(de)
|
1993-07-16 |
2002-05-15 |
Merck & Co Inc |
Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten
|
|
US5464788A
(en)
|
1994-03-24 |
1995-11-07 |
Merck & Co., Inc. |
Tocolytic oxytocin receptor antagonists
|
|
CA2195444A1
(en)
|
1994-07-20 |
1996-02-01 |
Bernhard Kohl |
Thiopyridyl compounds for controlling helicobacter bacteria
|
|
FR2731222A1
(fr)
|
1995-03-02 |
1996-09-06 |
Pf Medicament |
Nouveaux derives de piperazine aminoindoles cycliques, leur procede de preparation et leur utilisation a titre de medicaments
|
|
US5856326A
(en)
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5939418A
(en)
|
1995-12-21 |
1999-08-17 |
The Dupont Merck Pharmaceutical Company |
Isoxazoline, isothiazoline and pyrazoline factor Xa inhibitors
|
|
DE19548624A1
(de)
|
1995-12-23 |
1997-06-26 |
Boehringer Mannheim Gmbh |
Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US6333322B1
(en)
|
1996-03-13 |
2001-12-25 |
Eisai Co., Ltd. |
Nitrogen-containing tricyclic compounds and drugs containing the same
|
|
US5885995A
(en)
|
1996-04-03 |
1999-03-23 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5919785A
(en)
|
1996-04-03 |
1999-07-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5859012A
(en)
|
1996-04-03 |
1999-01-12 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036591A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5859015A
(en)
|
1996-04-03 |
1999-01-12 |
Merck & Co., Inc. |
N-heterocyclic piperazinyl and H-heterocyclic piperazinonyl inhibitors of farnesyl-protein transferase
|
|
DE19700431A1
(de)
|
1997-01-10 |
1998-07-16 |
Basf Ag |
Reaktivfarbstoffe mit einem Disulfonylanker
|
|
US6060038A
(en)
|
1997-05-15 |
2000-05-09 |
Merck & Co., Inc. |
Radiolabeled farnesyl-protein transferase inhibitors
|
|
US6403595B1
(en)
|
1998-02-05 |
2002-06-11 |
Takeda Chemical Industries, Ltd. |
Sulfonamide derivatives, processes for producing the same and utilization thereof
|
|
GB9806287D0
(en)
|
1998-03-24 |
1998-05-20 |
Synphar Lab Inc |
Monobactam enzyme inhibitors
|
|
TWI220143B
(en)
|
1998-05-13 |
2004-08-11 |
Solvay Pharm Gmbh |
Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds and novel cyclic compounds, and intermediate products
|
|
CA2332239A1
(en)
|
1998-05-15 |
1999-11-25 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds which inhibit parp activity
|
|
US6380193B1
(en)
|
1998-05-15 |
2002-04-30 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
|
|
US6509338B1
(en)
|
1998-06-22 |
2003-01-21 |
Bristol-Myers Squibb Company |
Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists
|
|
US6632836B1
(en)
|
1998-10-30 |
2003-10-14 |
Merck & Co., Inc. |
Carbocyclic potassium channel inhibitors
|
|
WO2000042852A1
(en)
|
1999-01-25 |
2000-07-27 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
AU3247700A
(en)
|
1999-03-03 |
2000-09-21 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
AU4005300A
(en)
|
1999-03-03 |
2000-09-21 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
WO2000051614A1
(en)
|
1999-03-03 |
2000-09-08 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferases
|
|
CA2363169A1
(en)
|
1999-03-03 |
2000-09-08 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
JP2002538120A
(ja)
|
1999-03-03 |
2002-11-12 |
メルク エンド カムパニー インコーポレーテッド |
プレニルタンパク質トランスフェラーゼの阻害剤
|
|
DE19911510A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
DE19911509A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
WO2000075135A1
(en)
|
1999-06-09 |
2000-12-14 |
Merck & Co., Inc. |
Biaryl inhibitors of prenyl-protein transferase
|
|
EP1106605A4
(en)
|
1999-06-24 |
2005-12-07 |
Toray Industries |
ANTAGONISTS OF THE ADRENERGIC RECEPTOR-ALPHA1B
|
|
AU6936500A
(en)
|
1999-08-24 |
2001-03-19 |
Regents Of The University Of California, The |
Non-quinoline inhibitors of malaria parasites
|
|
DE19944066A1
(de)
|
1999-09-14 |
2001-03-15 |
Byk Gulden Lomberg Chem Fab |
Inhibitoren der Tryptase
|
|
WO2001022963A1
(en)
|
1999-09-27 |
2001-04-05 |
Merck & Co., Inc. |
Method of preventing osteoporosis
|
|
BR0007174A
(pt)
|
1999-09-28 |
2001-09-04 |
Basf Ag |
Composto, preparação farmacêutica e uso de compostos
|
|
US20020010184A1
(en)
|
2000-02-18 |
2002-01-24 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
US20020052380A1
(en)
|
2000-02-18 |
2002-05-02 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
US20040110764A1
(en)
|
2000-04-10 |
2004-06-10 |
Stump Craig A. |
Inhibitors of prenyl-protein transferase
|
|
GB0012214D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
BR0107282A
(pt)
|
2000-09-29 |
2004-07-06 |
Cor Therapeutics Inc |
Composto, composição farmacêutica e métodos para prevenir ou tratar uma condição em um mamìfero e para inibir a coagulação de amostras biológicas
|
|
US6653102B2
(en)
|
2000-10-17 |
2003-11-25 |
Myriad Genetics, Inc. |
Nucleic acid encoding a phosphatase 2C that interacts with Fe 65
|
|
JPWO2002051836A1
(ja)
|
2000-12-27 |
2004-04-22 |
協和醗酵工業株式会社 |
ジペプチジルペプチダーゼ−ｉｖ阻害剤
|
|
SE0100902D0
(sv)
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
Compounds
|
|
EP1465867A1
(en)
|
2001-10-09 |
2004-10-13 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
WO2003053941A2
(en)
|
2001-12-20 |
2003-07-03 |
Bristol-Myers Squibb Company |
Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
|
|
WO2003053940A1
(en)
|
2001-12-20 |
2003-07-03 |
Bristol-Myers Squibb Company |
Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases
|
|
JP2005527492A
(ja)
|
2002-01-23 |
2005-09-15 |
イーライ・リリー・アンド・カンパニー |
メラノコルチン受容体アゴニスト
|
|
BR0308908A
(pt)
|
2002-04-03 |
2005-01-04 |
Topotarget Uk Ltd |
Composto, composição, uso de um composto, e, métodos para inibir a hdac em uma célula, para o tratamento de uma condição mediada pela hdac, de um condição proliferativa, de câncer e de psorìase
|
|
MXPA04010172A
(es)
|
2002-04-18 |
2005-02-03 |
Schering Corp |
1-(4-piperidinil)benzimidazolonas como antagonistas de histamina h3).
|
|
US7105505B2
(en)
|
2002-04-18 |
2006-09-12 |
Schering Corporation |
Benzimidazole derivatives useful as histamine H3 antagonists
|
|
BR0309671A
(pt)
|
2002-04-25 |
2005-05-03 |
Pharmacia Corp |
ácidos de piperidinil- e piperazinil-sulfonilmetil hidroxâmicos e seu uso como inibidores de protease
|
|
US20050209278A1
(en)
|
2002-04-25 |
2005-09-22 |
Mcdonald Joseph J |
Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
|
|
DE60309598T2
(de)
|
2002-06-24 |
2007-09-13 |
Schering Corp. |
Als histamin-h3-antagonisten geeignete indolderivate
|
|
US6906096B2
(en)
|
2002-06-28 |
2005-06-14 |
Irm Llc |
4,7-Disubstituted indoles and methods of making
|
|
AU2003259131A1
(en)
|
2002-07-09 |
2004-01-23 |
Bristol-Myers Squibb Company |
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
|
|
WO2004010942A2
(en)
|
2002-07-31 |
2004-02-05 |
Smithkline Beecham Corporation |
Substituted heterocyclic compounds as modulators of the ccr5 receptor
|
|
ES2399047T3
(es)
|
2002-09-20 |
2013-03-25 |
Merck Serono Sa |
Derivados de piperazina y procedimiento de uso
|
|
AU2003275632A1
(en)
|
2002-10-25 |
2004-05-13 |
Mitsubishi Pharma Corporation |
N-oxide compounds
|
|
US7452911B2
(en)
|
2002-10-31 |
2008-11-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
WO2004081643A1
(en)
|
2002-12-20 |
2004-09-23 |
Kaiser Aerospace & Electronics Corp. |
Lenslet array with polarization conversion
|
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
US20050043533A1
(en)
|
2003-03-25 |
2005-02-24 |
Babiak Kevin A. |
Process for making alpha-substituted hydroxamic acids
|
|
WO2004099179A1
(en)
|
2003-05-07 |
2004-11-18 |
Actelion Pharmaceuticals Ltd |
Piperazine-alkyl-ureido derivatives
|
|
ATE440825T1
(de)
|
2003-06-06 |
2009-09-15 |
Vertex Pharma |
Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
|
|
US7705052B2
(en)
*
|
2003-09-12 |
2010-04-27 |
Merck Serono Sa |
Sulfonamide derivatives for the treatment of diabetes
|
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
GB0328900D0
(en)
|
2003-12-12 |
2004-01-14 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1695961A4
(en)
|
2003-12-17 |
2007-10-24 |
Takeda Pharmaceutical |
UREA DERIVATIVE, METHOD FOR THE PRODUCTION AND THEIR USE
|
|
CA2548309A1
(en)
|
2003-12-22 |
2005-07-14 |
Amgen Inc. |
Aryl sulfonamide compounds and uses related thereto
|
|
JP2005232306A
(ja)
|
2004-02-19 |
2005-09-02 |
Fuji Photo Film Co Ltd |
光重合性組成物及びそれを用いた記録材料
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
US20080004263A1
(en)
|
2004-03-04 |
2008-01-03 |
Santora Vincent J |
Ligands of Follicle Stimulating Hormone Receptor and Methods of Use Thereof
|
|
US20050197336A1
(en)
|
2004-03-08 |
2005-09-08 |
Miikana Therapeutics Corporation |
Inhibitors of histone deacetylase
|
|
EP1744751A4
(en)
|
2004-03-18 |
2010-03-10 |
Brigham & Womens Hospital |
METHOD FOR THE TREATMENT OF SYNUCLEINOPATHIES
|
|
SE0400850D0
(sv)
|
2004-03-30 |
2004-03-31 |
Astrazeneca Ab |
Novel Compounds
|
|
US7345043B2
(en)
|
2004-04-01 |
2008-03-18 |
Miikana Therapeutics |
Inhibitors of histone deacetylase
|
|
WO2005117882A2
(en)
|
2004-04-20 |
2005-12-15 |
Incyte Corporation |
Hydroxamic acid derivatives as metalloprotease inhibitors
|
|
GB0408777D0
(en)
*
|
2004-04-20 |
2004-05-26 |
Glaxo Group Ltd |
Compounds
|
|
US7880001B2
(en)
|
2004-04-29 |
2011-02-01 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
PL1747210T3
(pl)
|
2004-05-07 |
2010-11-30 |
Warner Lambert Co |
Pochodne 3- lub 4-monopodstawionego fenolu i tiofenolu użyteczne jako ligandy H3
|
|
WO2005115374A1
(en)
|
2004-05-29 |
2005-12-08 |
7Tm Pharma A/S |
Crth2 receptor ligands for therapeutic use
|
|
EP1756056A1
(en)
|
2004-06-08 |
2007-02-28 |
Pfizer Products Inc. |
Aza-bicyclo[3.1.0]hex-1-yl derivatives active as nk1 antagonists
|
|
US20060241118A1
(en)
|
2004-06-18 |
2006-10-26 |
Celltech R&D Limited |
Hydroxamate sulfonamides as cd23 shedding inhibitors
|
|
CA2571824A1
(en)
|
2004-07-01 |
2006-01-19 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
WO2006008644A1
(en)
|
2004-07-13 |
2006-01-26 |
Pfizer Products Inc. |
Antidiabetic compounds
|
|
CN101065385A
(zh)
|
2004-07-22 |
2007-10-31 |
坎布里制药公司 |
治疗微生物感染的利福霉素衍生物
|
|
SE0401971D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidne derivatives
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
|
PE20060653A1
(es)
|
2004-08-31 |
2006-09-27 |
Glaxo Group Ltd |
Derivados triciclicos condensados como moduladores del receptor 5-ht1
|
|
EP2289510A1
(en)
|
2004-09-20 |
2011-03-02 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
|
|
US7547698B2
(en)
|
2004-09-20 |
2009-06-16 |
Xenon Pharmaceuticals Inc. |
Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)
|
|
JP4958786B2
(ja)
|
2004-09-20 |
2012-06-20 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
複素環誘導体および治療薬としてのそれらの使用
|
|
JP4330169B2
(ja)
|
2004-11-29 |
2009-09-16 |
国立大学法人名古屋大学 |
グリコペプチド抗生物質モノマー誘導体
|
|
RU2395502C2
(ru)
*
|
2004-12-09 |
2010-07-27 |
Ф.Хоффманн-Ля Рош Аг |
Производные фенил-пиперазин метанона
|
|
GB0428233D0
(en)
|
2004-12-23 |
2005-01-26 |
Glaxo Group Ltd |
Compounds
|
|
PE20061156A1
(es)
|
2004-12-23 |
2006-12-16 |
Glaxo Group Ltd |
Derivados de benzamida como agentes inhibidores del transportador de glicina
|
|
JP2008525398A
(ja)
|
2004-12-23 |
2008-07-17 |
グラクソ グループ リミテッド |
グリシン輸送阻害剤
|
|
GB0428232D0
(en)
|
2004-12-23 |
2005-01-26 |
Glaxo Group Ltd |
Compounds
|
|
PE20061330A1
(es)
|
2004-12-23 |
2006-12-27 |
Glaxo Group Ltd |
Compuestos derivados de benzamida como inhibidores del transportador de glicina
|
|
US7880002B2
(en)
|
2004-12-29 |
2011-02-01 |
Millennium Pharmaceuticals, Inc. |
Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
|
|
US7635698B2
(en)
|
2004-12-29 |
2009-12-22 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
AU2005324024B2
(en)
*
|
2005-01-07 |
2011-02-17 |
F. Hoffmann-La Roche Ag |
[4-(Heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
|
|
WO2006086255A2
(en)
|
2005-02-08 |
2006-08-17 |
Merck & Co., Inc. |
Inhibitors of checkpoint kinases
|
|
WO2006102423A1
(en)
|
2005-03-21 |
2006-09-28 |
Celera Genomics |
Alpha ketoamide compounds as cysteine protease inhibitors
|
|
DE102005014936A1
(de)
|
2005-03-24 |
2006-12-14 |
Abbott Gmbh & Co. Kg |
Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung
|
|
WO2006105127A2
(en)
|
2005-03-31 |
2006-10-05 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
GB0510140D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B2
|
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
|
CA2610196A1
(en)
|
2005-06-09 |
2006-12-14 |
Merck Frosst Canada Ltd. |
Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
US7728144B2
(en)
|
2005-06-13 |
2010-06-01 |
Theravance, Inc |
Biphenyl compounds useful as muscarinic receptor antagonists
|
|
EP1896453B1
(en)
|
2005-06-20 |
2009-12-02 |
Schering Corporation |
Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
|
|
JP2008546784A
(ja)
|
2005-06-20 |
2008-12-25 |
シェーリング コーポレイション |
ヒスタミンｈ３アンタゴニストとして有用なピペリジン誘導体
|
|
AU2006275568A1
(en)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
ES2382818T3
(es)
*
|
2005-09-29 |
2012-06-13 |
Merck Sharp & Dohme Corp. |
Inhibidores de transportadores glicina radiomarcados
|
|
ATE487706T1
(de)
*
|
2005-10-06 |
2010-11-15 |
Sanofi Aventis |
Cyclische n-ä1,3,4ü-thiadiazol-2-yl- benzsulfonamide, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
WO2007057742A2
(en)
|
2005-11-18 |
2007-05-24 |
Pfizer Products Inc. |
Novel piperazinone derivatives
|
|
EP1959947A2
(en)
|
2005-12-15 |
2008-08-27 |
Cytokinetics, Inc. |
Certain chemical entities, compositions and methods
|
|
BRPI0620386A2
(pt)
|
2005-12-21 |
2011-12-20 |
Schering Corp |
composição compreendendo a combinação de um antagonista de h3/agonista inverso e um supressor de apetite e uso da referida composição
|
|
CA2634940A1
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and h3 receptor antagonist/inverse agonist
|
|
JP2009521451A
(ja)
|
2005-12-21 |
2009-06-04 |
シェーリング コーポレイション |
ヒスタミンｈ３アンタゴニストとして有用な置換アニリン誘導体
|
|
EP1976848A2
(en)
|
2005-12-21 |
2008-10-08 |
Schering Corporation |
Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
|
|
EP1976513B1
(en)
|
2006-01-06 |
2016-08-24 |
Sunovion Pharmaceuticals Inc. |
Cycloalkylamines as monoamine reuptake inhibitors
|
|
GB0600427D0
(en)
|
2006-01-10 |
2006-02-15 |
Glaxo Group Ltd |
Compounds
|
|
BRPI0621027A2
(pt)
|
2006-01-13 |
2011-11-29 |
Pharmacyclics Inc |
composto, composição farmacêutica
|
|
WO2007087220A2
(en)
|
2006-01-25 |
2007-08-02 |
The Trustees Of Columbia University In The City Of New York |
The total synthesis of ecteinascidin 743 and derivatives thereof
|
|
US7632838B2
(en)
|
2006-02-07 |
2009-12-15 |
Wyeth |
11-beta HSD1 inhibitors
|
|
JP2009526014A
(ja)
|
2006-02-10 |
2009-07-16 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｃｘｃｒ３受容体拮抗薬としてのピペリジン誘導体
|
|
RU2318818C1
(ru)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
|
|
JPWO2007119833A1
(ja)
|
2006-04-14 |
2009-08-27 |
武田薬品工業株式会社 |
含窒素複素環化合物
|
|
US8017612B2
(en)
|
2006-04-18 |
2011-09-13 |
Japan Tobacco Inc. |
Piperazine compound and use thereof as a HCV polymerase inhibitor
|
|
BRPI0711352A2
(pt)
|
2006-05-09 |
2011-09-27 |
Merck & Co Inc |
composto, composição farmacêutica, e, métodos para o antagonismo de atividade receptora de cgrp em um mamìfero, e para, tratar, controlar, melhorar ou reduzir o risco de dor de cabeça, enxaqueca , ou cefaléia vascular
|
|
TW200808818A
(en)
|
2006-05-26 |
2008-02-16 |
Shionogi & Co |
Glycopeptide antibiotic derivatives
|
|
WO2007139150A1
(ja)
|
2006-05-30 |
2007-12-06 |
The University Of Tokushima |
ＴＮＦα阻害物質を含有してなる抗インフルエンザウイルス剤
|
|
EA200802415A1
(ru)
|
2006-06-09 |
2009-06-30 |
Икос Корпорейшн |
Замещенные фенилуксусные кислоты в качестве dp-2-антагонистов
|
|
GB0612420D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612437D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612416D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612425D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612435D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
UA94615C2
(uk)
*
|
2006-06-28 |
2011-05-25 |
Амген Інк. |
Інгібітори транспортера-1 гліцину
|
|
SG172685A1
(en)
*
|
2006-06-28 |
2011-07-28 |
Amgen Inc |
Glycine transporter-1 inhibitors
|
|
ES2604542T3
(es)
*
|
2006-06-29 |
2017-03-07 |
F. Hoffmann-La Roche Ag |
Arilamidas con sustitución tetrazol
|
|
JP2008013527A
(ja)
|
2006-07-10 |
2008-01-24 |
Sankyo Co Ltd |
チエノ［３，２−ｄ］ピリミジン−２，４−ジアミン誘導体
|
|
DE102006033114A1
(de)
|
2006-07-18 |
2008-01-24 |
Grünenthal GmbH |
Spirocyclische Azaindol-Derivate
|
|
CN101516366B
(zh)
|
2006-09-21 |
2012-05-30 |
霍夫曼-拉罗奇有限公司 |
作为抗癌剂的羟吲哚衍生物
|
|
GB0621607D0
(en)
|
2006-10-31 |
2006-12-06 |
Chroma Therapeutics Ltd |
Inhibitors of c-Met
|
|
EP2079746A2
(en)
|
2006-11-08 |
2009-07-22 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
|
AU2007316681B2
(en)
*
|
2006-11-09 |
2013-01-24 |
F. Hoffmann-La Roche Ag |
Thiazole and oxazole-substituted arylamides
|
|
WO2008061109A2
(en)
|
2006-11-15 |
2008-05-22 |
Forest Laboratories Holdings Limited |
Indazole derivatives useful as melanin concentrating receptor ligands
|
|
KR20080045537A
(ko)
|
2006-11-20 |
2008-05-23 |
에스케이케미칼주식회사 |
피리딘 화합물을 포함하는 간염 치료 및 예방 또는 간 보호효능을 갖는 약제 조성물
|
|
CN101558038B
(zh)
|
2006-11-30 |
2013-05-01 |
国立大学法人东京工业大学 |
姜黄素衍生物
|
|
EP2114166A4
(en)
|
2006-12-11 |
2011-05-25 |
Reviva Pharmaceuticals Inc |
COMPOSITIONS, SYNTHESIS, AND METHODS OF USING INDANONE-BASED CHOLINESTERASE INHIBITORS
|
|
DE102006060598A1
(de)
|
2006-12-21 |
2008-06-26 |
Merck Patent Gmbh |
Tetrahydrobenzoisoxazole
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
CA2677656A1
(en)
|
2007-02-07 |
2008-08-14 |
Wyeth |
Method for preparing halogenated amines
|
|
US20100216992A1
(en)
|
2007-02-27 |
2010-08-26 |
University Of South Florida |
Mimetic compositions and the production thereof
|
|
JP2010520917A
(ja)
|
2007-03-13 |
2010-06-17 |
ビオヴィトルム・アクチボラゲット（プブリクト） |
肥満治療用三環式イソキノリン誘導体
|
|
EP2137162B1
(en)
|
2007-03-15 |
2018-08-01 |
Novartis AG |
Organic compounds and their uses
|
|
JP5746860B2
(ja)
|
2007-04-09 |
2015-07-08 |
メチルジーン インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
JP2008266236A
(ja)
|
2007-04-23 |
2008-11-06 |
Kyorin Pharmaceut Co Ltd |
環状アミン誘導体又はその塩
|
|
GB0709031D0
(en)
|
2007-05-10 |
2007-06-20 |
Sareum Ltd |
Pharmaceutical compounds
|
|
WO2008145681A2
(en)
|
2007-05-31 |
2008-12-04 |
Boehringer Ingelheim International Gmbh |
Ccr2 receptor antagonists and uses thereof
|
|
JP2010208945A
(ja)
|
2007-06-01 |
2010-09-24 |
Mitsubishi Tanabe Pharma Corp |
複素環化合物
|
|
US20100184996A1
(en)
|
2007-06-20 |
2010-07-22 |
Glaxo Group Limited |
Process of amide formation
|
|
US7842696B2
(en)
*
|
2007-06-21 |
2010-11-30 |
Forest Laboratories Holdings Limited |
Piperazine derivatives as inhibitors of stearoyl-CoA desaturase
|
|
US20100286160A1
(en)
|
2007-06-28 |
2010-11-11 |
Intervet Inc. |
Substituted piperazines as cb1 antagonists
|
|
WO2009005645A1
(en)
|
2007-06-28 |
2009-01-08 |
Schering Corporation |
Substituted piperazines as cb1 antagonists
|
|
EP2548874A3
(en)
|
2007-06-28 |
2013-05-15 |
Intervet International B.V. |
Substituted piperazines as CB1 antagonists
|
|
TW200911808A
(en)
|
2007-07-23 |
2009-03-16 |
Astrazeneca Ab |
Novel compounds
|
|
JP5160827B2
(ja)
|
2007-07-25 |
2013-03-13 |
塩野義製薬株式会社 |
グリコペプチド抗生物質誘導体
|
|
JP5736098B2
(ja)
|
2007-08-21 |
2015-06-17 |
アッヴィ・インコーポレイテッド |
中枢神経系障害を治療するための医薬組成物
|
|
PT2304040T
(pt)
|
2008-07-04 |
2017-11-21 |
Scientist Of Fortune Sa |
Produção de alcenos por descarboxilação enzimática de ácidos 3-hidroxi-alcanoicos
|
|
US9045445B2
(en)
|
2010-06-04 |
2015-06-02 |
Albany Molecular Research, Inc. |
Glycine transporter-1 inhibitors, methods of making them, and uses thereof
|